Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-18-011289)

Filing Details

Accession Number:: 0000899243-18-011289
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-05-03 16:30:38
Reporting Period:: 2018-05-01

Accepted Time:: 2018-05-03 16:30:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1521036	Lantheus Holdings Inc.	LNTH	In Vitro & In Vivo Diagnostic Substances (2835)	352318913

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1610664	Cesare Orlandi	C/O Lantheus Holdings, Inc. 331 Treble Cove Road North Billerica MA 01862	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-05-01	3,794	$18.05	91,522	No	4	S	Direct
Common Stock	Disposition	2018-05-01	716	$18.00	90,806	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2018.